TABLE 2.
Characteristics of hospital participants, Spain, 1996
| Characteristic | No. of respondents (response rate [%]) | No. (%) of hospitals |
|---|---|---|
| Noncategorical variablesa | ||
| No. of licensed beds | 22 (100.0) | |
| Rate of VRE prevalence | 20 (90.9) | |
| Categorical variables | ||
| University affiliation | 14 (63.6) | 6 (42.9) |
| Medium or small sizeb | 22 (100.0) | 15 (68.2) |
| Population >50,000 | 13 (59.1) | 12 (92.3) |
| β-Lactamase test | 22 (100) | 11 (50.0) |
| Agar screening test | 10 (45.5) | 0 (0.0) |
| E test | 22 (100.0) | 1 (4.5) |
| Routine antibiotic sus-ceptibility testing | ||
| Blood | ||
| Vancomycin | 22 (100) | 22 (100.0) |
| Ampicillin | 22 (100) | 22 (100.0) |
| Penicillin | 20 (90.9) | 19 (95.0) |
| Aminoglycosides | 20 (90.9) | 19 (95.0) |
| Urine | ||
| Vancomycin | 22 (100) | 19 (86.4) |
| Ampicillin | 22 (100) | 22 (100) |
| Penicillin | 21 (95.4) | 15 (71.4) |
| Aminoglycosides | 20 (90.9) | 13 (65.0) |
a
The medians (ranges) for number of licensed beds and rate of VRE prevalence were 473 (96 to 1,250) and 0.25 (0 to 9), respectively.
b
Medium or small size is <600 beds.